tradingkey.logo
tradingkey.logo

Agilent Technologies Inc

A
148.520USD
+2.760+1.89%
終値 01/09, 16:00ET15分遅れの株価
42.04B時価総額
32.37直近12ヶ月PER

Agilent Technologies Inc

148.520
+2.760+1.89%

詳細情報 Agilent Technologies Inc 企業名

Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.

Agilent Technologies Incの企業情報

企業コードA
会社名Agilent Technologies Inc
上場日Nov 18, 1999
最高経営責任者「CEO」Mcdonnell (Padraig)
従業員数- -
証券種類Ordinary Share
決算期末Nov 18
本社所在地5301 Stevens Creek Blvd
都市SANTA CLARA
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号95051
電話番号14083458886
ウェブサイトhttps://www.agilent.com/
企業コードA
上場日Nov 18, 1999
最高経営責任者「CEO」Mcdonnell (Padraig)

Agilent Technologies Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Boon Hwee Koh
Mr. Boon Hwee Koh
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
61.55K
+1273.00%
Mr. Rodney Gonsalves
Mr. Rodney Gonsalves
Vice President, Corporate Controller, Principal Accounting Officer
Vice President, Corporate Controller, Principal Accounting Officer
48.88K
+426.00%
Dr. George A. Scangos, Ph.D.
Dr. George A. Scangos, Ph.D.
Independent Director
Independent Director
38.35K
+1819.00%
Dr. Daniel K. Podolsky, M.D.
Dr. Daniel K. Podolsky, M.D.
Independent Director
Independent Director
35.68K
--
Mr. Dow R. Wilson
Mr. Dow R. Wilson
Independent Director
Independent Director
18.04K
+1819.00%
Ms. Mala Anand
Ms. Mala Anand
Independent Director
Independent Director
14.55K
+1819.00%
Dr. Simon May
Dr. Simon May
Senior Vice President, Agilent President, Life Sciences and Diagnostics Markets Group
Senior Vice President, Agilent President, Life Sciences and Diagnostics Markets Group
13.80K
+6481.00%
Mr. Adam Stewart Elinoff
Mr. Adam Stewart Elinoff
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
11.73K
+11726.00%
Dr. Otis W. Brawley, M.D.
Dr. Otis W. Brawley, M.D.
Independent Director
Independent Director
10.73K
+2631.00%
Dr. Mikael G. Dolsten, M.D., Ph.D.
Dr. Mikael G. Dolsten, M.D., Ph.D.
Independent Director
Independent Director
4.95K
-2600.00%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Boon Hwee Koh
Mr. Boon Hwee Koh
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
61.55K
+1273.00%
Mr. Rodney Gonsalves
Mr. Rodney Gonsalves
Vice President, Corporate Controller, Principal Accounting Officer
Vice President, Corporate Controller, Principal Accounting Officer
48.88K
+426.00%
Dr. George A. Scangos, Ph.D.
Dr. George A. Scangos, Ph.D.
Independent Director
Independent Director
38.35K
+1819.00%
Dr. Daniel K. Podolsky, M.D.
Dr. Daniel K. Podolsky, M.D.
Independent Director
Independent Director
35.68K
--
Mr. Dow R. Wilson
Mr. Dow R. Wilson
Independent Director
Independent Director
18.04K
+1819.00%
Ms. Mala Anand
Ms. Mala Anand
Independent Director
Independent Director
14.55K
+1819.00%

収益内訳

通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Non-instrumentation and other
4.52B
65.07%
Instrumentation
2.43B
34.93%
地域別USD
会社名
収益
比率
United States
2.81B
40.39%
Asia Pacific
2.22B
31.94%
Europe
1.92B
27.68%
事業別
地域別
事業別USD
会社名
収益
比率
Non-instrumentation and other
4.52B
65.07%
Instrumentation
2.43B
34.93%

株主

更新時刻: Sun, Nov 16
更新時刻: Sun, Nov 16
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.96%
BlackRock Institutional Trust Company, N.A.
5.27%
State Street Investment Management (US)
4.39%
MFS Investment Management
4.06%
Wellington Management Company, LLP
3.31%
他の
71.01%
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.96%
BlackRock Institutional Trust Company, N.A.
5.27%
State Street Investment Management (US)
4.39%
MFS Investment Management
4.06%
Wellington Management Company, LLP
3.31%
他の
71.01%
種類
株主統計
比率
Investment Advisor
43.92%
Investment Advisor/Hedge Fund
37.07%
Hedge Fund
3.08%
Pension Fund
1.84%
Insurance Company
1.67%
Research Firm
1.61%
Bank and Trust
1.43%
Sovereign Wealth Fund
1.23%
Family Office
0.44%
他の
7.71%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
2060
260.68M
91.95%
-5.94M
2025Q3
2120
261.17M
95.32%
-153.68K
2025Q2
2118
261.09M
93.90%
+1.73M
2025Q1
2146
261.16M
94.63%
-8.63M
2024Q4
2129
260.37M
94.60%
-340.38K
2024Q3
2073
260.94M
95.43%
-3.57M
2024Q2
2043
263.64M
96.52%
-5.86M
2024Q1
2043
270.13M
95.69%
-10.33M
2023Q4
2063
269.78M
93.21%
+5.05M
2023Q3
1993
263.26M
94.34%
-4.53M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
33.91M
11.96%
+39.32K
+0.12%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
14.95M
5.27%
+91.77K
+0.62%
Sep 30, 2025
State Street Investment Management (US)
12.44M
4.39%
-12.77K
-0.10%
Sep 30, 2025
MFS Investment Management
11.51M
4.06%
-681.27K
-5.59%
Sep 30, 2025
Wellington Management Company, LLP
9.38M
3.31%
+433.34K
+4.84%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
8.15M
2.87%
-13.65K
-0.17%
Sep 30, 2025
Geode Capital Management, L.L.C.
7.40M
2.61%
+81.19K
+1.11%
Sep 30, 2025
Generation Investment Management LLP
6.36M
2.24%
+582.09K
+10.08%
Sep 30, 2025
Pictet Asset Management Ltd.
5.26M
1.85%
+485.39K
+10.17%
Sep 30, 2025
DWS Investment GmbH
4.55M
1.6%
+741.64K
+19.48%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Honeytree US Equity ETF
5.06%
First Trust Water ETF
4.76%
Goldman Sachs Future Health Care Equity ETF
3.87%
VanEck Morningstar Wide Moat Value ETF
3.31%
Madison Covered Call ETF
3.27%
iShares Health Innovation Active ETF
2.9%
VanEck Morningstar Wide Moat ETF
2.87%
Argent Mid Cap ETF
2.57%
Global X Genomics & Biotechnology ETF
2.4%
Invesco Zacks Mid-Cap ETF
2.29%
詳細を見る
Honeytree US Equity ETF
比率5.06%
First Trust Water ETF
比率4.76%
Goldman Sachs Future Health Care Equity ETF
比率3.87%
VanEck Morningstar Wide Moat Value ETF
比率3.31%
Madison Covered Call ETF
比率3.27%
iShares Health Innovation Active ETF
比率2.9%
VanEck Morningstar Wide Moat ETF
比率2.87%
Argent Mid Cap ETF
比率2.57%
Global X Genomics & Biotechnology ETF
比率2.4%
Invesco Zacks Mid-Cap ETF
比率2.29%

配当金

過去5年間の配当金総支払額は 1.31B 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Nov 19, 2025
A.NB Interim Cash Dividend of gross USD 0.255 paid on Jan 28, 2026 going ex on Jan 06, 2026 with reinvestment option
Jan 06, 2026
Jan 28, 2026
Jan 06, 2026
Sep 17, 2025
A.NB Final Cash Dividend of gross USD 0.248 paid on Oct 22, 2025 going ex on Sep 30, 2025 with reinvestment option
Sep 30, 2025
Oct 22, 2025
Sep 30, 2025
May 21, 2025
A.NB Interim Cash Dividend of gross USD 0.248 paid on Jul 23, 2025 going ex on Jul 01, 2025 with reinvestment option
Jul 01, 2025
Jul 23, 2025
Jul 01, 2025
Feb 19, 2025
A.NB Interim Cash Dividend of gross USD 0.248 paid on Apr 23, 2025 going ex on Apr 01, 2025 with reinvestment option
Apr 01, 2025
Apr 23, 2025
Apr 01, 2025
Nov 20, 2024
A.NB Interim Cash Dividend of gross USD 0.248 paid on Jan 22, 2025 going ex on Dec 31, 2024 with reinvestment option
Dec 31, 2024
Jan 22, 2025
Dec 31, 2024
Sep 18, 2024
A.NB Final Cash Dividend of gross USD 0.236 paid on Oct 23, 2024 going ex on Oct 01, 2024 with reinvestment option
Oct 01, 2024
Oct 23, 2024
Oct 01, 2024
May 22, 2024
A.NB Interim Cash Dividend of gross USD 0.236 paid on Jul 24, 2024 going ex on Jul 02, 2024
Jul 02, 2024
Jul 24, 2024
Jul 02, 2024
Feb 21, 2024
A.NB Interim Cash Dividend of gross USD 0.236 paid on Apr 24, 2024 going ex on Apr 01, 2024
Apr 02, 2024
Apr 24, 2024
Apr 01, 2024
Nov 16, 2023
A.NB Interim Cash Dividend of gross USD 0.236 paid on Jan 24, 2024 going ex on Dec 29, 2023
Jan 02, 2024
Jan 24, 2024
Dec 29, 2023
Sep 21, 2023
A.NB Final Cash Dividend of gross USD 0.225 paid on Oct 25, 2023 going ex on Oct 02, 2023 with reinvestment option
Oct 03, 2023
Oct 25, 2023
Oct 02, 2023
詳細を見る

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Agilent Technologies Incの上位5名の株主は誰ですか?

Agilent Technologies Incの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は33.91M株を保有しており、これは全体の11.96%に相当します。
BlackRock Institutional Trust Company, N.A.は14.95M株を保有しており、これは全体の5.27%に相当します。
State Street Investment Management (US)は12.44M株を保有しており、これは全体の4.39%に相当します。
MFS Investment Managementは11.51M株を保有しており、これは全体の4.06%に相当します。
Wellington Management Company, LLPは9.38M株を保有しており、これは全体の3.31%に相当します。

Agilent Technologies Incの株主タイプ上位3種は何ですか?

Agilent Technologies Incの株主タイプ上位3種は、
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)

Agilent Technologies Inc(A)の株式を保有している機関の数はいくつですか?

2025Q4時点で、Agilent Technologies Incの株式を保有している機関は2060社あり、保有株式の総市場価値は約260.68Mで、全体の91.95%を占めています。2025Q3と比較して、機関の持ち株は-3.37%増加しています。

Agilent Technologies Incの最大の収益源は何ですか?

FY2025において、Non-instrumentation and other部門がAgilent Technologies Incにとって最大の収益を生み出しており、その金額は4.52Bで、全収益の65.07%を占めています。
KeyAI